2026-10-07 21:26:11 UTC#428613newconfirmednews
DCOY stock news
DCOY stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire11 wire items
2026-09-29 11:30:00 UTC#383692duplicateconfirmednews
Decoy Therapeutics reports preclinical PK data for DCOY-CoV supporting once-weekly intranasal dosing
2026-09-29 11:30:00 UTC#383689newconfirmedpress release
Decoy Therapeutics reports DCOY-CoV preclinical data showing once-weekly intranasal dosing potential
2026-09-22 22:14:00 UTC#352177correctionconfirmedpress release
Decoy Therapeutics (DCOY) corrects warrant terms: new warrants are immediately exercisable
2026-09-22 22:14:00 UTC#352176correctionconfirmednews
Decoy Therapeutics (DCOY) clarifies new warrants are immediately exercisable without stockholder approval
2026-09-22 16:50:00 UTC#350543newconfirmedpress release
Decoy Therapeutics (DCOY) Announces $3.85 Million Warrant Inducement Transaction
2026-08-13 11:00:11 UTC#171127newforecastnews
Decoy Therapeutics (DCOY) Q2 2026 Earnings Preview: Analysts Expect $2.88 Loss Per Share
2026-08-07 11:00:03 UTC#144474newforecastnews
Decoy Therapeutics (DCOY) Q2 2026 earnings preview: analysts forecast ($2.88) EPS
2026-08-03 13:00:00 UTC#116873newconfirmedpress release
Decoy Therapeutics expands IP portfolio to 7 patent families and 19 pending applications for D-MAVs and IMP³ACT platform
2026-07-27 13:00:00 UTC#82044newconfirmedpress release
Decoy Therapeutics (DCOY) D-MAV platform shows in vitro activity against Ebola Zaire virus
pr_newswireimportance 0.40trust 0.90Decoy Therapeutics Inc. +0.50Texas Biomedical Research Institute +0.30Ebola Zaire +0.40+2 entities
2026-07-15 13:26:00 UTC#35907newconfirmednews